D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PUT
Pultegroup
PHM
$24.5B
| – | – |
-56,700
| Closed | -$1.47M |
|
3802
Polaris
PII
$4.15B
| – | – |
-5,284
| Closed | -$448K |
|
3803
CALL
POSCO
PKX
$15.8B
| – | – |
-20,000
| Closed | -$1.1M |
|
3804
CALL
Planet Fitness
PLNT
$4.23B
| – | – |
-8,200
| Closed | -$440K |
|
|
3805
PUT
Planet Fitness
PLNT
$4.23B
| – | – |
-14,600
| Closed | -$783K |
|
3806
CALL
PNC Financial Services
PNC
$100B
| – | – |
-48,200
| Closed | -$5.63M |
|
3807
Pinnacle West Capital
PNW
$12.9B
| – | – |
-175,629
| Closed | -$15M |
|
3808
CALL
Pool Corp
POOL
$6.7B
| – | – |
-15,000
| Closed | -$2.23M |
|
3809
PUT
Pilgrim's Pride
PPC
$6.82B
| – | – |
-21,200
| Closed | -$329K |
|
3810
PPG Industries
PPG
$25.9B
| – | – |
-1,968
| Closed | -$201K |
|
|
PPL
3811
PUT
PPL Corp
PPL
$27.3B
| – | – |
-10,400
| Closed | -$295K |
|
3812
CALL
Protolabs
PRLB
$1.86B
| – | – |
-33,000
| Closed | -$3.72M |
|
3813
ProQR Therapeutics
PRQR
$243M
| – | – |
-21,436
| Closed | -$338K |
|
3814
PUT
Prothena Corp
PRTA
$458M
| – | – |
-46,000
| Closed | -$474K |
|
3815
Pearson
PSO
$9.78B
| – | – |
-45,770
| Closed | -$546K |
|
3816
CALL
PTC
PTC
$13.7B
| – | – |
-12,700
| Closed | -$1.05M |
|
|
3817
PTC
PTC
$13.7B
| – | – |
-219,108
| Closed | -$18.2M |
|
|
3818
PUT
PTC
PTC
$13.7B
| – | – |
-10,300
| Closed | -$854K |
|
3819
PUT
Patterson-UTI
PTEN
$3.87B
| – | – |
-18,100
| Closed | -$187K |
|
|
BCIC
3820
BCP Investment Corp
BCIC
$86.9M
| – | – |
-1,041
| Closed | -$36K |
|
3821
Prudential
PUK
$36.5B
| – | – |
-31,963
| Closed | -$1.1M |
|
3822
ProPetro Holding
PUMP
$1.45B
| – | – |
-10,192
| Closed | -$126K |
|
3823
Quantum Corp
QMCO
$437M
| – | – |
-23,869
| Closed | -$955K |
|
3824
CALL
Ferrari
RACE
$63.3B
| – | – |
-7,600
| Closed | -$756K |
|
|
3825
Ferrari
RACE
$63.3B
| – | – |
-6,047
| Closed | -$741K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.